Skip to main content

Table 1 Patients’ subgroups according to the treatment received

From: The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

Subgroup

MACOP-B

Rituximab

Radiotherapy

n(%)

1

Yes

No

No

11 (11.2%)

2

Yes

Yes

No

20 (20.4%)

3

Yes

Yes

Yes

37 (37.8%)

4

Yes

No

Yes

30 (30.6%)

Total (%)

98 (100%)

57 (58.2%)

67 (68.4%)

98 (100%)